| pubmed-article:11792961 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11792961 | lifeskim:mentions | umls-concept:C0005695 | lld:lifeskim |
| pubmed-article:11792961 | lifeskim:mentions | umls-concept:C0120285 | lld:lifeskim |
| pubmed-article:11792961 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:11792961 | lifeskim:mentions | umls-concept:C0021102 | lld:lifeskim |
| pubmed-article:11792961 | lifeskim:mentions | umls-concept:C0598934 | lld:lifeskim |
| pubmed-article:11792961 | lifeskim:mentions | umls-concept:C0079809 | lld:lifeskim |
| pubmed-article:11792961 | lifeskim:mentions | umls-concept:C1710493 | lld:lifeskim |
| pubmed-article:11792961 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:11792961 | pubmed:issue | 2 Pt 1 | lld:pubmed |
| pubmed-article:11792961 | pubmed:dateCreated | 2002-1-16 | lld:pubmed |
| pubmed-article:11792961 | pubmed:abstractText | Bladder cancer is a common malignancy in which local recurrence and distant failure contribute to poor patient outcome. The search for improved therapies remains a high priority in this disease. For most experimental therapies animal tumor models represent an important step between in vitro testing and clinical trials. A useful animal model of bladder cancer involves the orthotopic implantation of bladder tumor cells in sygeneic animals. This model offers the opportunity to test the efficacy of therapies administered systemically or intravesically. However, quantitation of tumor growth has been difficult. | lld:pubmed |
| pubmed-article:11792961 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11792961 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11792961 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11792961 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11792961 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11792961 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11792961 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11792961 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11792961 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11792961 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:11792961 | pubmed:author | pubmed-author:ClineMarkM | lld:pubmed |
| pubmed-article:11792961 | pubmed:author | pubmed-author:TortiSuzy VSV | lld:pubmed |
| pubmed-article:11792961 | pubmed:author | pubmed-author:Golden-FleetM... | lld:pubmed |
| pubmed-article:11792961 | pubmed:author | pubmed-author:WillinghamMar... | lld:pubmed |
| pubmed-article:11792961 | pubmed:author | pubmed-author:MaRongR | lld:pubmed |
| pubmed-article:11792961 | pubmed:author | pubmed-author:SakimotoYoshi... | lld:pubmed |
| pubmed-article:11792961 | pubmed:author | pubmed-author:TortiFrank... | lld:pubmed |
| pubmed-article:11792961 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11792961 | pubmed:volume | 167 | lld:pubmed |
| pubmed-article:11792961 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11792961 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11792961 | pubmed:pagination | 724-8 | lld:pubmed |
| pubmed-article:11792961 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:meshHeading | pubmed-meshheading:11792961... | lld:pubmed |
| pubmed-article:11792961 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11792961 | pubmed:articleTitle | Use of green fluorescent protein to measure tumor growth in an implanted bladder tumor model. | lld:pubmed |
| pubmed-article:11792961 | pubmed:affiliation | Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. | lld:pubmed |
| pubmed-article:11792961 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11792961 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
